Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2019
Argatroban to achieve therapeutic anticoagulation in two patients with acute thrombosis and heparin resistanceIrina Mindlina, Elizabeth Nelmes, Megan Sharp, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 11, 2021
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studiesMichael J R Desborough, Samya Obaji, Gillian C Lowe, et al.Journal of Thrombosis and Haemostasis : JTH|September 2, 2022
Outcomes and management of pregnancy in women with bleeding disorder of unknown causeDaniel Castle, Michael J R Desborough, Michelle Kemp, et al.International Journal of Laboratory Hematology|July 21, 2021
Investigation of platelet function in patients with chronic kidney disease stages IV-VAli Khalid, Danielle White, Megan Sharp, et al.Journal of Thrombosis and Haemostasis : JTH|June 12, 2024
Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand FactorClaire Kelly, Will Thomas, Ross I Baker, et al.Seminars in Thrombosis and Hemostasis|August 19, 2025
Machine Learning in Venous Thromboembolism - Why and What Next?Gerard Gurumurthy, Filip Kisiel, Lianna Reynolds, et al.Nutrition and Cancer|April 30, 2008
Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancerJill M Hamilton-Reeves, Salome A Rebello, Will Thomas, et al.International Journal of Laboratory Hematology|November 21, 2019
Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatmentStephen MacDonald, Alfie Wright, Frederik Beuche, et al.Blood Advances|December 18, 2024
Cost-effectiveness of Voncento prophylaxis vs on-demand treatment in von Willebrand disease in the United KingdomMichele Wilson, Giancarlo Castaman, Will Thomas, et al.British Journal of Haematology|April 17, 2022
The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpuraAndrew J Doyle, Matthew J Stubbs, Will Lester, et al.Pageof 4